AIHCC
Index Performance
-0.43%
AIHCC
-2.65%
NBI
-2.09%
ICEBIOT
Overview
Description
The Intelligent Healthcare Conviction strategy (AIHC) uses OpenAI's ChatGPT, Google's Bard, and Inflection AI's Claude to build an equal weighted portfolio of the committee's highest conviction US-listed stocks in the healthcare sector. The strategy aims to create superior quality-focused returns compared to the MSCI US Investable Market Health Care 25/50 Index.
- TickerAIHCC
- Inception Date10/16/2023
- WeightingEqual
- # of holdings30
What's inside?
Holdings
All holdings as of December 8, 2023
CSV download
| DexCom, Inc. (DXCM) | 4.68% | $45.194B | 26.69% | 63.75% | 11.55x |
| Insulet Corp. (PODD) | 4.43% | $13.593B | 26.97% | 68.36% | 8.01x |
| IDEXX Laboratories, Inc. (IDXX) | 3.92% | $44.130B | 8.78% | 59.72% | 10.46x |
| ResMed, Inc. (RMD) | 3.70% | $23.957B | 16.00% | 53.30% | 5.28x |
| Intuitive Surgical, Inc. (ISRG) | 3.63% | $109.290B | 11.96% | 66.94% | 14.35x |
| Zimmer Biomet Holdings, Inc. (ZBH) | 3.55% | $24.513B | 5.02% | 60.83% | 3.95x |
| Medtronic Plc (MDT) | 3.51% | $105.508B | 5.26% | 60.10% | 3.44x |
| Boston Scientific Corp. (BSX) | 3.50% | $80.501B | 11.26% | 61.44% | 6.28x |
| Penumbra, Inc. (PEN) | 3.50% | $8.647B | 26.80% | 64.67% | 9.51x |
| Stryker Corp. (SYK) | 3.47% | $109.840B | 9.60% | 61.52% | 5.84x |
| Danaher Corp. (DHR) | 3.31% | $160.709B | -10.31% | 58.20% | 6.63x |
| Elevance Health, Inc. (ELV) | 3.30% | $112.303B | 7.29% | N/A | 0.76x |
| GE Healthcare Technologies, Inc. (GEHC) | 3.30% | $31.193B | N/A | 39.03% | 2.03x |
| UnitedHealth Group, Inc. (UNH) | 3.30% | $508.496B | 14.18% | N/A | 1.51x |
| AbbVie, Inc. (ABBV) | 3.26% | $263.559B | -5.97% | 68.84% | 5.65x |
| Thermo Fisher Scientific, Inc. (TMO) | 3.25% | $189.234B | -0.96% | 40.97% | 5.20x |
| Johnson & Johnson (JNJ) | 3.21% | $371.732B | -10.36% | 69.53% | 4.23x |
| Merck & Co., Inc. (MRK) | 3.21% | $262.905B | 5.20% | 70.74% | 4.96x |
| Hologic, Inc. (HOLX) | 3.19% | $16.409B | -0.84% | 52.27% | 4.30x |
| Eli Lilly & Co. (LLY) | 3.17% | $567.733B | 36.84% | 80.42% | 15.62x |
| Edwards Lifesciences Corp. (EW) | 3.17% | $41.958B | 12.27% | 75.71% | 7.07x |
| Gilead Sciences, Inc. (GILD) | 3.16% | $98.462B | 0.59% | 77.75% | 4.08x |
| Amgen, Inc. (AMGN) | 3.07% | $144.027B | 4.36% | 73.71% | 6.40x |
| AstraZeneca PLC (AZN) | 3.07% | $196.920B | -2.79% | 73.15% | 5.24x |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.02% | $90.228B | 9.33% | 87.15% | 8.30x |
| Becton, Dickinson & Co. (BDX) | 2.88% | $67.461B | 6.85% | 33.44% | 4.68x |
| Biogen, Inc. (BIIB) | 2.88% | $34.673B | 6.20% | 67.78% | 4.44x |
| Pfizer Inc. (PFE) | 2.87% | $162.504B | -41.55% | 19.87% | 3.02x |
| Bristol Myers Squibb Co. (BMY) | 2.85% | $102.369B | -2.25% | 56.72% | 3.37x |
| Shockwave Medical, Inc. (SWAV) | 2.67% | $6.427B | 41.64% | 86.82% | 11.10x |
Market data by FactSet
